{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T14:07:17Z","timestamp":1774534037209,"version":"3.50.1"},"publisher-location":"New York, NY","reference-count":36,"publisher":"Springer US","isbn-type":[{"value":"9781071640906","type":"print"},{"value":"9781071640913","type":"electronic"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/7651_2023_503","type":"book-chapter","created":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T11:02:15Z","timestamp":1696590135000},"page":"203-213","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["GMP-Based Isolation of Full-Term Human Placenta-Derived NK Cells for CAR-NK Cell Therapy in Malignant Melanoma"],"prefix":"10.1007","author":[{"given":"Peyvand Parhizkar","family":"Roudsari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sepideh","family":"Alavi-Moghadam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid Reza","family":"Aghayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rasta","family":"Arjmand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kambiz","family":"Gilany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa","family":"Rezaei-Tavirani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Babak","family":"Arjmand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,10,7]]},"reference":[{"key":"503_CR1","doi-asserted-by":"crossref","unstructured":"Aghayan HR, Payab M, Mohamadi-Jahani F et al (2021) GMP-compliant production of human placenta-derived mesenchymal stem cells. Stem Cells and Good Manufacturing practices: Methods, Protocols, and Regulations:213\u2013225","DOI":"10.1007\/7651_2020_282"},{"key":"503_CR2","doi-asserted-by":"crossref","unstructured":"Alavi-Moghadam S, Sarvari M, Goodarzi P et al (2020) The importance of cleanroom facility in manufacturing biomedical products. Biomedical Product Development: Bench to Bedside:69\u201379","DOI":"10.1007\/978-3-030-35626-2_7"},{"issue":"9","key":"503_CR3","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s41434-021-00246-w","volume":"28","author":"N Albinger","year":"2021","unstructured":"Albinger N, Hartmann J, Ullrich E (2021) Current status and perspective of CAR-T and CAR-NK cell therapy trials in Germany. Gene Ther 28(9):513\u2013527. https:\/\/doi.org\/10.1038\/s41434-021-00246-w","journal-title":"Gene Ther"},{"key":"503_CR4","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.675310","volume":"9","author":"B Arjmand","year":"2021","unstructured":"Arjmand B, Alavi-Moghadam S, Parhizkar Roudsari P et al (2021) COVID-19 pathology on various organs and regenerative medicine and stem cell-based interventions. Front Cell Dev Biol 9:675310","journal-title":"Front Cell Dev Biol"},{"key":"503_CR5","doi-asserted-by":"crossref","unstructured":"Arjmand B, Alavi-Moghadam S, Rezaei-Tavirani M et al (2022) GMP-compliant mesenchymal stem cell-derived exosomes for cell-free therapy in cancer. In: Springer","DOI":"10.1007\/7651_2022_467"},{"key":"503_CR6","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3389\/fgene.2022.824451","volume":"13","author":"B Arjmand","year":"2022","unstructured":"Arjmand B, Hamidpour SK, Tayanloo-Beik A et al (2022) Machine learning: a new prospect in multi-omics data analysis of cancer. Front Genet 13:76","journal-title":"Front Genet"},{"key":"503_CR7","unstructured":"biowest.net\/s181a-fetal-bovine-serum-fbs-biopharm-edqm-certified\/ (2023)"},{"issue":"1","key":"503_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1590\/s0037-86822000000100004","volume":"33","author":"BC Catalan-Soares","year":"2000","unstructured":"Catalan-Soares BC, Almeida RT, Carneiro-Proietti AB (2000) Prevalence of HIV-1\/2, HTLV-I\/II, hepatitis B virus (HBV), hepatitis C virus (HCV), Treponema pallidum and Trypanosoma cruzi among prison inmates at Manhua\u00e7u, Minas Gerais State, Brazil. Rev Soc Bras Med Trop 33(1):27\u201330. https:\/\/doi.org\/10.1590\/s0037-86822000000100004","journal-title":"Rev Soc Bras Med Trop"},{"issue":"16","key":"503_CR9","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1101\/gad.1437206","volume":"20","author":"L Chin","year":"2006","unstructured":"Chin L, Garraway LA, Fisher DE (2006) Malignant melanoma: genetics and therapeutics in the genomic era. Genes Dev 20(16):2149\u20132182","journal-title":"Genes Dev"},{"issue":"4","key":"503_CR10","doi-asserted-by":"publisher","DOI":"10.1002\/cti2.1274","volume":"10","author":"M Daher","year":"2021","unstructured":"Daher M, Melo Garcia L, Li Y et al (2021) CAR-NK cells: the next wave of cellular therapy for cancer. Clin Transl Immunol 10(4):e1274. https:\/\/doi.org\/10.1002\/cti2.1274","journal-title":"Clin Transl Immunol"},{"key":"503_CR11","doi-asserted-by":"crossref","unstructured":"Ebrahimi-Barough S, Ai J, Payab M et al (2021) Standard operating procedure for the good manufacturing practice-compliant production of human endometrial stem cells for multiple sclerosis. Stem Cells and Good Manufacturing Practices: Methods, Protocols, and Regulations:199\u2013212","DOI":"10.1007\/7651_2020_281"},{"issue":"1","key":"503_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1634\/theoncologist.2010-0190","volume":"16","author":"C Garbe","year":"2011","unstructured":"Garbe C, Eigentler TK, Keilholz U et al (2011) Systematic review of medical treatment in melanoma: current status and future prospects. Oncologist 16(1):5\u201324","journal-title":"Oncologist"},{"key":"503_CR13","unstructured":"https:\/\/www.cherwell-labs.co.uk\/cherwell-labs-post\/environmental-monitoring-how-to-maintain-a-cleanroom (2023)"},{"key":"503_CR14","unstructured":"https:\/\/www.gmpsop.com\/what-is-environmental-monitoring-in-pharmaceutical-industry\/ (2023)"},{"key":"503_CR15","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s10561-012-9355-8","volume":"14","author":"J Klykens","year":"2013","unstructured":"Klykens J, Pirnay J-P, Verbeken G et al (2013) Cleanrooms and tissue banking how happy I could be with either GMP or GTP? Cell Tissue Bank 14:571\u2013578","journal-title":"Cell Tissue Bank"},{"issue":"13_Supplement","key":"503_CR16","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1158\/1538-7445.am2019-2319","volume":"79","author":"BQ Lam","year":"2019","unstructured":"Lam BQ, Sugase T, Terai M et al (2019) Abstract 2319: accumulation and anti-tumor effect of chimeric antigen receptor (CAR) NK cells in metastasis uveal melanoma. Cancer Res 79(13_Supplement):2319. https:\/\/doi.org\/10.1158\/1538-7445.am2019-2319","journal-title":"Cancer Res"},{"key":"503_CR17","doi-asserted-by":"crossref","unstructured":"Larijani B, Aghayan H-R, Goodarzi P et al (2015) GMP-grade human fetal liver-derived mesenchymal stem cells for clinical transplantation. Stem Cells and Good Manufacturing Practices: Methods, Protocols, and Regulations:123\u2013136","DOI":"10.1007\/7651_2014_101"},{"issue":"1\u20132","key":"503_CR18","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jri.2012.06.002","volume":"95","author":"G Laskarin","year":"2012","unstructured":"Laskarin G, Medancic SS, Redzovic A et al (2012) Specific decidual CD14+ cells hamper cognate NK cell proliferation and cytolytic mediator expression after mucin 1 treatment in vitro. J Reprod Immunol 95(1\u20132):36\u201345","journal-title":"J Reprod Immunol"},{"key":"503_CR19","doi-asserted-by":"publisher","unstructured":"Lee H, Da Silva IP, Palendira U et al (2021) Targeting NK cells to enhance melanoma response to immunotherapies. Cancers 13(6). https:\/\/doi.org\/10.3390\/cancers13061363","DOI":"10.3390\/cancers13061363"},{"issue":"1","key":"503_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13045-020-01014-w","volume":"14","author":"S Liu","year":"2021","unstructured":"Liu S, Galat V, Galat Y et al (2021) NK cell-based cancer immunotherapy: from basic biology to clinical development. J Hematol Oncol 14(1):7. https:\/\/doi.org\/10.1186\/s13045-020-01014-w","journal-title":"J Hematol Oncol"},{"key":"503_CR21","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/bs.mie.2019.05.036","volume":"631","author":"S Lorenzo-Herrero","year":"2020","unstructured":"Lorenzo-Herrero S, Sordo-Bahamonde C, Gonz\u00e1lez S et al (2020) Evaluation of NK cell cytotoxic activity against malignant cells by the calcein assay. Methods Enzymol 631:483\u2013495. https:\/\/doi.org\/10.1016\/bs.mie.2019.05.036","journal-title":"Methods Enzymol"},{"issue":"1","key":"503_CR22","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/(SICI)1097-0320(20000101)39:1<72::AID-CYTO10>3.0.CO;2-R","volume":"39","author":"R Mendes","year":"2000","unstructured":"Mendes R, Bromelow K, Westby M et al (2000) Flow cytometric visualisation of cytokine production by CD3-CD56+ NK cells and CD3+ CD56+ NK\u2013T cells in whole blood. Cytometry 39(1):72\u201378","journal-title":"Cytometry"},{"issue":"7","key":"503_CR23","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.4049\/jimmunol.1502570","volume":"196","author":"T Michel","year":"2016","unstructured":"Michel T, Poli A, Cuapio A et al (2016) Human CD56bright NK cells: an update. J Immunol 196(7):2923\u20132931","journal-title":"J Immunol"},{"key":"503_CR24","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/B978-0-12-813726-0.00010-6","volume-title":"Transfusion medicine and hemostasis","author":"K Peck","year":"2019","unstructured":"Peck K (2019) Chapter 10 - Serologic testing of donor products. In: Shaz BH, Hillyer CD, Reyes Gil M (eds) Transfusion medicine and hemostasis, 3rd edn. Elsevier, pp 59\u201361. https:\/\/doi.org\/10.1016\/B978-0-12-813726-0.00010-6","edition":"3"},{"issue":"3","key":"503_CR25","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1177\/17534259211001512","volume":"27","author":"AS Perera Molligoda Arachchige","year":"2021","unstructured":"Perera Molligoda Arachchige AS (2021) Human NK cells: from development to effector functions. Innate Immun 27(3):212\u2013229. https:\/\/doi.org\/10.1177\/17534259211001512","journal-title":"Innate Immun"},{"issue":"4","key":"503_CR26","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1365-2567.2008.03027.x","volume":"126","author":"A Poli","year":"2009","unstructured":"Poli A, Michel T, Th\u00e9r\u00e9sine M et al (2009) CD56bright natural killer (NK) cells: an important NK cell subset. Immunology 126(4):458\u2013465","journal-title":"Immunology"},{"key":"503_CR27","doi-asserted-by":"crossref","unstructured":"Sheikh Hosseini M, Parhizkar Roudsari P, Gilany K et al (2020) Cellular dust as a novel hope for regenerative cancer medicine. Cell Biology and Translational Medicine, Volume 9: Stem Cell-Based Therapeutic Approaches in Disease:139\u2013160","DOI":"10.1007\/5584_2020_537"},{"issue":"12","key":"503_CR28","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1111\/exd.13792","volume":"27","author":"B Simon","year":"2018","unstructured":"Simon B, Uslu U (2018) CAR-T cell therapy in melanoma: a future success story? Exp Dermatol 27(12):1315\u20131321. https:\/\/doi.org\/10.1111\/exd.13792","journal-title":"Exp Dermatol"},{"issue":"2","key":"503_CR29","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/j.1365-3083.2006.01883.x","volume":"65","author":"E Takahashi","year":"2007","unstructured":"Takahashi E, Kuranaga N, Satoh K et al (2007) Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16\u2212 CD56bright NK cells but also from CD16\u2212 CD56dim NK cells. Scand J Immunol 65(2):126\u2013138","journal-title":"Scand J Immunol"},{"key":"503_CR30","doi-asserted-by":"publisher","unstructured":"van Vliet AA, Georgoudaki AM, Raimo M et al (2021) Adoptive NK cell therapy: a promising treatment prospect for metastatic melanoma. Cancers 13(18). https:\/\/doi.org\/10.3390\/cancers13184722","DOI":"10.3390\/cancers13184722"},{"issue":"3","key":"503_CR31","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1128\/iai.41.3.992-997.1983","volume":"41","author":"DA Weigent","year":"1983","unstructured":"Weigent DA, Stanton GJ, Johnson HM (1983) Interleukin 2 enhances natural killer cell activity through induction of gamma interferon. Infect Immun 41(3):992\u2013997. https:\/\/doi.org\/10.1128\/iai.41.3.992-997.1983","journal-title":"Infect Immun"},{"issue":"17","key":"503_CR32","doi-asserted-by":"publisher","first-page":"5191","DOI":"10.1158\/1078-0432.ccr-18-1550","volume":"25","author":"SA Weiss","year":"2019","unstructured":"Weiss SA, Wolchok JD, Sznol M (2019) Immunotherapy of melanoma: facts and hopes. Clin Cancer Res 25(17):5191\u20135201. https:\/\/doi.org\/10.1158\/1078-0432.ccr-18-1550","journal-title":"Clin Cancer Res"},{"key":"503_CR33","doi-asserted-by":"publisher","unstructured":"Wrona E, Borowiec M, Potemski P (2021) CAR-NK cells in the treatment of solid tumors. Int J Mol Sci 22(11). https:\/\/doi.org\/10.3390\/ijms22115899","DOI":"10.3390\/ijms22115899"},{"key":"503_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102975","volume":"59","author":"G Xie","year":"2020","unstructured":"Xie G, Dong H, Liang Y et al (2020) CAR-NK cells: a promising cellular immunotherapy for cancer. EBioMedicine 59:102975. https:\/\/doi.org\/10.1016\/j.ebiom.2020.102975","journal-title":"EBioMedicine"},{"issue":"4","key":"503_CR35","first-page":"1770","volume":"11","author":"L Zhang","year":"2021","unstructured":"Zhang L, Liu M, Yang S et al (2021) Natural killer cells: of-the-shelf cytotherapy for cancer immunosurveillance. Am J Cancer Res 11(4):1770\u20131791","journal-title":"Am J Cancer Res"},{"issue":"10","key":"503_CR36","doi-asserted-by":"publisher","first-page":"2732","DOI":"10.7150\/thno.18752","volume":"7","author":"L Zhu","year":"2017","unstructured":"Zhu L, Kalimuthu S, Gangadaran P et al (2017) Exosomes derived from natural killer cells exert therapeutic effect in melanoma. Theranostics 7(10):2732","journal-title":"Theranostics"}],"container-title":["Methods in Molecular Biology","Skin Stem Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/7651_2023_503","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,19]],"date-time":"2024-07-19T05:02:17Z","timestamp":1721365337000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/7651_2023_503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9781071640906","9781071640913"],"references-count":36,"URL":"https:\/\/doi.org\/10.1007\/7651_2023_503","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"7 October 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}